Chemistry Rx Compounding and Specialty Pharmacy
Lars Brichta PharmD PhD is currently serving as the Chief Scientific Officer and Director of Clinical and Scientific Affairs at Chemistry Rx Compounding and Specialty Pharmacy. Previously, Lars Brichta worked as a Biotech Equity Research Associate at Canaccord Genuity Group Inc., and as a Senior Neuroscientist at Rockefeller University. Lars Brichta's research focuses on neurodegenerative diseases, particularly Parkinson's disease. Lars Brichta also has experience as a Researcher at the National Institutes of Health, with a background in G protein-coupled receptors. Lars Brichta holds a PhD in Neurogenetics from the University of Cologne and a Doctor of Pharmacy degree from The Martin Luther University of Halle-Wittenberg.
This person is not in any teams
Chemistry Rx Compounding and Specialty Pharmacy
Chemistry Rx is an ACHC & URAC accredited compounding and specialty pharmacy located in Folcroft, PA. Licensed in all 50 states, our mission is to provide exceptional service to our patients, providers and DTC telemedicine partners. The unique aspect about our services is our clinically-centered approach, assessing the patient's primary problem and recommending novel treatment options where compound therapies could play a significant role. Through extensive networking and research, we provide evidence based recommendations for complex cases where minimal drug therapies currently exist. Our multidisciplinary team consisting of pharmacists and nurses, have experience managing patients requiring compounded therapies for various diseases and conditions, acute and chronic, and in both adult and pediatric populations. "Overall, our pharmacists and nurses provide exceptional clinical services and ensure patient satisfaction. We are ready to take on the most challenging patient cases. Personalizing medicine, one compound at a time."